These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 9439556)

  • 1. Management of newly diagnosed non-insulin-dependent diabetes mellitus in the primary care setting: effects of 2 years of gliclazide treatment--the Diadem Study.
    Cathelineau G; de Champvallins M; Bouallouche A; Lesobre B
    Metabolism; 1997 Dec; 46(12 Suppl 1):31-4. PubMed ID: 9439556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
    Ohkubo Y; Kishikawa H; Araki E; Miyata T; Isami S; Motoyoshi S; Kojima Y; Furuyoshi N; Shichiri M
    Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Diabetes Care; 1996 Nov; 19(11):1243-8. PubMed ID: 8908388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
    Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
    Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and associated features of albuminuria in Koreans with NIDDM.
    Lee KU; Park JY; Kim SW; Lee MH; Kim GS; Park SK; Park JS
    Diabetes Care; 1995 Jun; 18(6):793-9. PubMed ID: 7555505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of micro and macroangiopatic chronic complications and their risk factors in the care of out patients with type 2 diabetes mellitus].
    Scheffel RS; Bortolanza D; Weber CS; Costa LA; Canani LH; Santos KG; Crispim D; Roisenberg I; Lisbôa HR; Tres GS; Tschiedel B; Gross JL
    Rev Assoc Med Bras (1992); 2004; 50(3):263-7. PubMed ID: 15499476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIDDM: new once-daily intervention for type 2 diabetes mellitus: Diaprel MR.
    Ionescu-Tîrgovişte C; Gavrilă L; Brădescu OM; Guja C
    Rom J Intern Med; 2004; 42(2):431-40. PubMed ID: 15529633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of diabetic retinopathy and nephropathy in Polynesians of Western Samoa.
    Collins VR; Dowse GK; Plehwe WE; Imo TT; Toelupe PM; Taylor HR; Zimmet PZ
    Diabetes Care; 1995 Aug; 18(8):1140-9. PubMed ID: 7587849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.
    Chen J; Gall MA; Yokoyama H; Jensen JS; Deckert M; Parving HH
    Diabetes Care; 1996 Feb; 19(2):130-4. PubMed ID: 8718432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polish Multicenter Study on Diabetes Epidemiology (PMSDE)--1998-2000].
    Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):751-8. PubMed ID: 11928582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of diabetic retinopathy, ischemic heart disease, and albuminuria with diabetic treatment in type 2 diabetic patients. A population-based study.
    Weitzman S; Maislos M; Bodner-Fishman B; Rosen S
    Acta Diabetol; 1997 Dec; 34(4):275-9. PubMed ID: 9451472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension, hyperlipidemia, and abdominal obesity and the development of microalbuminuria in patients with non-insulin-dependent diabetes mellitus.
    Spangler JG; Konen JC
    J Am Board Fam Pract; 1996; 9(1):1-6. PubMed ID: 8770803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of gliclazide on plasma lipids and pancreatic beta cell function in non-insulin-dependent diabetes mellitus.
    Chen KW; Juang JH; Huang HS; Lin JD; Huang BY; Huang MJ
    Changgeng Yi Xue Za Zhi; 1993 Dec; 16(4):246-50. PubMed ID: 8313208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus.
    McKenna K; Thompson C
    Scott Med J; 1997 Aug; 42(4):99-104. PubMed ID: 9507584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control.
    Vestergaard H; Lund S; Bjørbaek C; Pedersen O
    Diabetologia; 1995 Oct; 38(10):1230-8. PubMed ID: 8690177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of gliclazide with insulin as initial treatment modality in newly diagnosed type 2 diabetes.
    Chandra ST; Priya G; Khurana ML; Jyotsna VP; Sreenivas V; Dwivedi S; Ammini AC
    Diabetes Technol Ther; 2008 Oct; 10(5):363-8. PubMed ID: 18715212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes.
    Betteridge DJ; Vergès B
    Diabetologia; 2005 Dec; 48(12):2477-81. PubMed ID: 16283239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a sulfonylurea (gliclazide) treatment on insulin sensitivity and glucose-mediated glucose disposal in patients with non-insulin-dependent diabetes mellitus (NIDDM).
    Wajchenberg BL; Santomauro AT; Porrelli RN
    Diabetes Res Clin Pract; 1993 May; 20(2):147-54. PubMed ID: 8375268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Fasting Hyperglycaemia Study: III. Randomized controlled trial of sulfonylurea therapy in subjects with increased but not diabetic fasting plasma glucose.
    Karunakaran S; Hammersley MS; Morris RJ; Turner RC; Holman RR
    Metabolism; 1997 Dec; 46(12 Suppl 1):56-60. PubMed ID: 9439561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.